君实生物(01877)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01877 君实生物

未开盘 08-11 16:08:13

19.770

+0.350

+1.80%

最高20.280	最低19.440	成交量350.76万
今开19.500	昨收19.420	日振幅4.33%
总市值203.04亿	流通市值51.40亿	总股本10.27亿
成交额6,975万	换手率1.35%	流通股本2.60亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01877","market":"HK","secType":"STK","nameCN":"君实生物","latestPrice":19.77,"timestamp":1786435693004,"preClose":19.42,"halted":0,"volume":3507600,"delay":0,"changeRate":0.018022657054582794,"floatShares":260000000,"shares":1027000000,"eps":-0.87,"marketStatus":"未开盘","change":0.35,"latestTime":"08-11 16:08:13","open":19.5,"high":20.28,"low":19.44,"amount":69748235,"amplitude":0.043254,"askPrice":19.77,"askSize":3800,"bidPrice":19.7,"bidSize":16400,"shortable":3,"etf":0,"ttmEps":-0.691,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1786498200000},"marketStatusCode":0,"adr":0,"listingDate":1545580800000,"exchange":"SEHK","adjPreClose":19.42,"openAndCloseTimeList":[[1786411800000,1786420800000],[1786424400000,1786435200000]],"volumeRatio":1.58431,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688180","market":"SH","secType":"STK","nameCN":"君实生物-U","latestPrice":38.49,"timestamp":1786431600000,"preClose":38.91,"halted":0,"volume":21075300,"delay":0,"premium":"-55.84"}},"requestUrl":"/m/hq/s/01877","defaultTab":"news","newsList":[{"id":"2658882932","title":"君实生物（688180）披露股东减持股份结果公告，8月10日股价下跌0.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658882932","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658882932?lang=zh_cn&edition=full","pubTime":"2026-08-10 22:04","pubTimestamp":1786370699,"startTime":"0","endTime":"0","summary":"截至2026年8月10日收盘，君实生物报收于38.91元，较前一交易日下跌0.84%，最新总市值为399.49亿元。近日，君实生物发布《关于股东减持股份结果公告》。公告显示，本次减持计划实施前，贺铭女士持有公司股份3,531,380股，占公司总股本的0.3440%。因个人资金需求，贺铭女士计划通过集中竞价方式减持不超过882,600股，减持比例不超过公司总股本的0.0860%。本次减持已实施完毕，当前持股数量为2,647,980股，持股比例降至0.2579%。本次减持符合相关法规及此前披露的减持计划。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000033616.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1515","BK0239","BK1583","688180","01877","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165617962","title":"君实生物：上海檀英及一致行动人合计持股降至5.96% 触及1%权益变动刻度","url":"https://stock-news.laohu8.com/highlight/detail?id=1165617962","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1165617962?lang=zh_cn&edition=full","pubTime":"2026-08-10 21:20","pubTimestamp":1786368039,"startTime":"0","endTime":"0","summary":"2026年8月11日，君实生物公告称，公司持股5%以上股东上海檀英投资合伙企业及其一致行动人Loyal Valley Capital Advantage Fund II LP、LVC Renaissance Fund LP于2026年6月16日至2026年8月10日期间通过大宗交易方式合计减持公司股份1,004.0000万股。减持后，三方合计持股数量由7,125.7999万股降至6,121.7999万股，占公司总股本比例由6.94%降至5.96%，触及1%权益变动刻度。其中，上海檀英直接持股从5,549.9326万股降至4,545.9326万股，持股比例由5.41%降至4.43%；LVC Fund II和LVC Renaissance Fund的持股数量及比例均保持不变，分别为784.2673万股和791.6000万股。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a3893e2538b44a4c9453f52433cb6ed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120802507","title":"君实生物(01877)股东贺铭完成减持88.26万股 套现约3,354万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1120802507","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1120802507?lang=zh_cn&edition=full","pubTime":"2026-08-10 21:10","pubTimestamp":1786367451,"startTime":"0","endTime":"0","summary":"上海君实生物医药科技股份有限公司8月11日披露股东减持结果公告。公司股东贺铭已于2026年7月3日至2026年8月10日期间，通过集中竞价方式累计减持公司股份882,600股，占公司总股本的0.0860%，减持计划已全部实施完毕。本次减持成交价格区间为35.76元/股至40.34元/股，对应成交总金额33,543,382.60元，折合约3,354.34万元。减持前，贺铭持有公司3,531,380股，占总股本的0.3440%。公告称，本次减持计划的实施符合相关法律法规及此前披露的减持计划安排。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658313449","title":"君实生物(01877)股东贺铭累计减持88.26万股股份 减持计划已实施完毕","url":"https://stock-news.laohu8.com/highlight/detail?id=2658313449","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658313449?lang=zh_cn&edition=full","pubTime":"2026-08-10 21:07","pubTimestamp":1786367240,"startTime":"0","endTime":"0","summary":"智通财经APP讯，君实生物(01877)公布，公司于近日收到贺铭女士出具的《关于君实生物减持股份结果的告知函》，贺铭女士本次减持计划已实施完毕，累计减持88.26万股股份，减持总金额约3354.34万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1478180.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1583","BK1515","01877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658382982","title":"8月10日君实生物现1笔大宗交易 机构净买入3606.98万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2658382982","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658382982?lang=zh_cn&edition=full","pubTime":"2026-08-10 17:43","pubTimestamp":1786355018,"startTime":"0","endTime":"0","summary":"证券之星消息，8月10日君实生物发生大宗交易，交易数据如下：大宗交易成交价格38.66元，相对当日收盘价折价0.64%，成交93.3万股，成交金额3606.98万元，买方营业部为机构专用，卖方营业部为中信证券股份有限公司上海浦东新区东方路证券营业部。近三个月该股共发生21笔大宗交易，合计成交14.0万手，折价成交21笔。截至2026年8月10日收盘，君实生物报收于38.91元，下跌0.84%，换手率3.66%，成交量28.09万手，成交额11.03亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000023168.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1583","01877","BK1161","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658567360","title":"每周股票复盘：机构连续三日净买入君实生物（688180）","url":"https://stock-news.laohu8.com/highlight/detail?id=2658567360","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658567360?lang=zh_cn&edition=full","pubTime":"2026-08-09 01:20","pubTimestamp":1786209620,"startTime":"0","endTime":"0","summary":"来自公司公告汇总：截至2026年7月31日，君实生物H股与A股股本及已发行股份无变动。交易信息汇总8月7日君实生物现1笔大宗交易，机构净买入2924.25万元8月6日君实生物现1笔大宗交易，机构净买入2754万元8月5日君实生物现1笔大宗交易，机构净买入2802万元公司公告汇总上海君实生物医药科技股份有限公司截至2026年7月31日的证券变动月报表显示，公司H股和A股的法定/注册股本、已发行股份及库存股份数目均无变动。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080900000144.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688180","BK1583","BK1515","01877","BK0239","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657452441","title":"股市必读：君实生物新发布《君实生物H股公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2657452441","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657452441?lang=zh_cn&edition=full","pubTime":"2026-08-06 02:29","pubTimestamp":1785954550,"startTime":"0","endTime":"0","summary":"大宗交易8月5日君实生物发生1笔大宗交易，机构净买入2802万元。公司公告汇总君实生物H股公告上海君实生物医药科技股份有限公司截至2026年7月31日的证券变动月报表显示，公司H股和A股的法定/注册股本、已发行股份及库存股份数目均无变动。当月未发生股份增减，股份期权计划项下亦无新股发行或库存股转让。确认公众持股量符合上市规则要求，且所有证券发行均已获董事会授权并遵守相关法规。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080600001978.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","BK1583","BK1515","01877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657252319","title":"君实生物（688180）披露截至2026年7月31日证券变动月报表，8月5日股价上涨2.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657252319","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657252319?lang=zh_cn&edition=full","pubTime":"2026-08-05 22:36","pubTimestamp":1785940577,"startTime":"0","endTime":"0","summary":"截至2026年8月5日收盘，君实生物报收于37.6元，较前一交易日上涨2.51%，最新总市值为386.04亿元。该股当日开盘36.54元，最高38.2元，最低36.45元，成交额达5.6亿元，换手率为1.94%。公告显示，公司H股和A股的法定/注册股本、已发行股份及库存股份数目均无变动。H股于港交所上市，A股于上交所科创板上市。确认公众持股量符合上市规则要求，且所有证券发行均已获董事会授权并遵守相关法规。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500043701.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","01877","BK1583","BK0239","688180","BK1161","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657651038","title":"8月5日君实生物现1笔大宗交易 机构净买入2802万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2657651038","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657651038?lang=zh_cn&edition=full","pubTime":"2026-08-05 17:50","pubTimestamp":1785923447,"startTime":"0","endTime":"0","summary":"证券之星消息，8月5日君实生物发生大宗交易，交易数据如下：大宗交易成交价格37.36元，相对当日收盘价折价0.64%，成交75万股，成交金额2802万元，买方营业部为机构专用，卖方营业部为中信证券股份有限公司上海浦东新区东方路证券营业部。近三个月该股共发生18笔大宗交易，合计成交11.57万手，折价成交18笔。截至2026年8月5日收盘，君实生物报收于37.6元，上涨2.51%，换手率1.94%，成交量14.87万手，成交额5.6亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500032854.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1583","01877","BK1515","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657470512","title":"花旗集团在君实生物的H股好仓比例下降0.57%至5.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657470512","media":"南方财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657470512?lang=zh_cn&edition=full","pubTime":"2026-08-05 17:09","pubTimestamp":1785920974,"startTime":"0","endTime":"0","summary":"南财智讯8月5日电，香港交易所披露信息显示，CitigroupInc.（花旗集团）在君实生物的H股好仓（L）比例于7月29日从6.10%下降至5.53%。同时淡仓（S）比例从5.06%降至4.49%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608053832649131.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608053832649131.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1162221912.USD","LU1791807156.HKD","LU2360032135.SGD","LU0106831901.USD","LU0130517989.USD","LU0098860793.USD","IE00BSNM7G36.USD","LU1267930227.SGD","LU0310800965.SGD","LU0477156953.USD","FTXO","LU1074936037.SGD","C","LU0170899867.USD","LU1244550577.SGD","LU0130102774.USD","BK4207","LU2417539215.USD","LU0072461881.USD","LU2125154935.USD","BK4585","BK4588","LU0314106906.USD","BK4504","LU1244550494.USD","LU0052756011.USD","LU0648001328.SGD","LU0162691827.USD","LU1201861249.SGD","LU2236285917.USD","LU1506573853.SGD","BK1161","IYF","TFNS","LU2125154778.USD","LU1668664300.SGD","BK1583","LU0203347892.USD","LU2462157665.USD","BK4534","BK4559","LU0320765646.SGD","BK1515","01877","LU0128525689.USD","LU0203345920.USD","LU2456880835.USD","LU1366192091.USD","LU1244550221.USD","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151833699","title":"君实生物发布2026年7月股份变动月报，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1151833699","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1151833699?lang=zh_cn&edition=full","pubTime":"2026-08-05 16:44","pubTimestamp":1785919471,"startTime":"0","endTime":"0","summary":"上海君实生物医药科技股份有限公司于2026年8月5日披露了截至2026年7月31日止的股份变动月报表，报告期内公司股本结构保持稳定，未发生新增发行、回购或注销等事项。根据公告，截至2026年7月31日，君实生物注册股本合计为人民币1,026,689,871元。截至2026年7月末，H股已授出13,210,000份期权，本月底可供行使的股份期权所对应的股份总数为64,227,400股，A股已授出24,700,000份期权，本月底可供行使的股份期权所对应的股份总数为815,871股。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656316636","title":"每周股票复盘：君实生物（688180）现两笔机构大宗净买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2656316636","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656316636?lang=zh_cn&edition=full","pubTime":"2026-08-02 01:40","pubTimestamp":1785606024,"startTime":"0","endTime":"0","summary":"截至2026年7月31日收盘，君实生物报收于36.51元，较上周的35.88元上涨1.76%。君实生物当前最新总市值374.84亿元，在生物制品板块市值排名3/51，在两市A股市值排名508/5202。7月27日君实生物发生1笔大宗交易，机构净买入2039.95万元。会议审议通过《关于回购公司H股股份一般性授权的议案》，该议案为特别决议议案，获出席股东所持表决权三分之二以上通过，并对A股中小投资者单独计票。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080200000302.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["01877","688180","BK1515","BK0239","BK1583","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655852750","title":"君实生物：公司未调整2025年年度报告营业收入的相关披露口径","url":"https://stock-news.laohu8.com/highlight/detail?id=2655852750","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655852750?lang=zh_cn&edition=full","pubTime":"2026-07-29 15:33","pubTimestamp":1785310423,"startTime":"0","endTime":"0","summary":"投资者提问：董秘您好，报告显示公司 2025 年总营收 24.98 亿元，同比增长 28.23%；核心主业营收 24.62 亿元，同比增长 31.28%。请问董秘，公司调整营收披露口径，合并相关业务列报的原因是什么？公司未调整2025年年度报告营业收入的相关披露口径，根据公司2025年年度报告，2025年营业收入24.98亿元，其中药品销售收入23.01亿元，技术许可及特许权使用收入1.61亿元，技术服务及其他收入0.36亿元，2024年技术服务及其他收入0.73亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072900020588.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["01877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655252852","title":"君实生物：JS207正处于II期临床研究阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2655252852","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655252852?lang=zh_cn&edition=full","pubTime":"2026-07-29 15:33","pubTimestamp":1785310423,"startTime":"0","endTime":"0","summary":"证券之星消息，君实生物07月29日在投资者关系平台上答复投资者关心的问题。请问贵司JS207关键性注册临床研究进展如何？JS207正处于II期临床研究阶段，正在多个瘤种中开展与化疗、单抗、ADC等不同药物的联合探索。JS207与JS212联合用药的II期临床试验正在进行。未来公司计划基于前期临床数据，将JS207快速推进至关键注册临床阶段。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072900020587.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["01877","BK1161","BK1515","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655832649","title":"【券商聚焦】国泰海通证券：全球多肽CDMO进入产能扩张周期","url":"https://stock-news.laohu8.com/highlight/detail?id=2655832649","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655832649?lang=zh_cn&edition=full","pubTime":"2026-07-29 09:21","pubTimestamp":1785288070,"startTime":"0","endTime":"0","summary":"国内外的多肽CDMO公司均加大对于产能的投资建设，尤其注重从临床前到商业化生产的一站式服务能力建设。2026年4月，凯莱英医药与天津经开区管委会签署合作备忘录，在天津经开区持续扩建化学大分子创新药CDMO研发生产基地，预计投资规模达20亿元人民币。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250109/MWIyNWQwZjQ4NTQyNjI4OTI5NDE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWIyNWQwZjQ4NTQyNjI4OTI5NDE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1986985","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","06160","LU1720050803.USD","BK1564","02616","LU1251922891.USD","LU0052750758.USD","LU0979878070.USD","LU2476274308.USD","02611","09995","BK1141","01177","BK1610","LU0359202008.SGD","601211","LU0051755006.USD","SG9999002463.SGD","IE00B0JY6N72.USD","01801","BK1574","LU0561508036.HKD","LU0348784397.USD","KURE","LU1008478684.HKD","BK1147","LU0181495838.USD","CDMO","IE00B543WZ88.USD","LU1719994722.HKD","01877","LU1328277881.USD","161027","02142","LU0307460666.USD","02269","09688","LU2242644610.SGD","01093","BK1588","06185","09926","KCE","LU0588546209.SGD","LU0417516738.SGD","LU0634319403.HKD","HK0000165453.HKD","LU0067412154.USD","IE00B5MMRT66.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654008906","title":"7月28日君实生物现1笔大宗交易 机构净买入1998.09万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2654008906","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654008906?lang=zh_cn&edition=full","pubTime":"2026-07-28 17:52","pubTimestamp":1785232342,"startTime":"0","endTime":"0","summary":"证券之星消息，7月28日君实生物发生大宗交易，交易数据如下：大宗交易成交价格35.49元，相对当日收盘价折价0.64%，成交56.3万股，成交金额1998.09万元，买方营业部为机构专用，卖方营业部为中信证券股份有限公司上海浦东新区东方路证券营业部。近三个月该股共发生17笔大宗交易，合计成交10.82万手，折价成交17笔。本文数据来源于上海证券交易所大宗交易信息披露，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072800029306.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1583","BK1161","01877","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654020804","title":"上海医药、君实生物等成立新私募基金 出资额15亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2654020804","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654020804?lang=zh_cn&edition=full","pubTime":"2026-07-28 11:18","pubTimestamp":1785208680,"startTime":"0","endTime":"0","summary":"【上海医药、君实生物等成立新私募基金 出资额15亿】天眼查App显示，近日，上海上实生物医药产业私募基金合伙企业（有限合伙）成立，执行事务合伙人为上海上实资本管理有限公司、上海上实生物医药管理咨询有限公司，出资额15亿人民币，经营范围为以私募基金从事股权投资、投资管理、资产管理等活动。合伙人信息显示，该基金由上海国投先导生物医药私募投资基金合伙企业（有限合伙）、上海医药集团股份有限公司、上海君实生物医药科技股份有限公司等共同出资。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607283823297587.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607283823297587.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1583","BK0097","BK0209","BK0196","02607","BK0188","601607","BK0020","BK1515","BK1161","BK0028","BK0184","BK0099","BK0187","BK0183","BK0175","BK0012","01877","BK1197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654045230","title":"君实生物（688180）披露关于回购公司H股股份一般性授权的议案获通过，7月27日股价上涨4.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2654045230","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654045230?lang=zh_cn&edition=full","pubTime":"2026-07-27 22:13","pubTimestamp":1785161631,"startTime":"0","endTime":"0","summary":"截至2026年7月27日收盘，君实生物报收于37.33元，较前一交易日上涨4.04%，最新总市值为383.26亿元。该股当日开盘36.09元，最高38.2元，最低35.41元，成交额达6.5亿元，换手率为2.29%。出席会议股东共353人，代表有表决权股份总数270,778,987股，占公司总表决权数的26.3950%。会议审议通过《关于回购公司H股股份一般性授权的议案》，该议案为特别决议议案，获出席股东所持表决权三分之二以上通过，并对A股中小投资者单独计票。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072700034679.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["01877","BK1161","BK1583","688180","BK0239","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131306242","title":"君实生物股东会通过H股回购一般性授权 逾99%赞成","url":"https://stock-news.laohu8.com/highlight/detail?id=1131306242","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1131306242?lang=zh_cn&edition=full","pubTime":"2026-07-27 19:06","pubTimestamp":1785150386,"startTime":"0","endTime":"0","summary":"上海君实生物医药科技股份有限公司2026年第一次临时股东大会已于2026年7月27日在上海市浦东新区召开。会议以现场结合网络投票方式进行，由董事长熊俊主持。本次会议共有353名股东及股东代理人出席，合计代表表决权270,778,987股，占公司全部表决权的26.3950%，其中A股股东表决权占比23.0305%，H股股东表决权占比3.3644%。大会审议并以特别决议方式通过了“关于回购公司H股股份一般性授权的议案”。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654064965","title":"股市必读：7月24日君实生物现1笔大宗交易 机构净买入1960.75万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2654064965","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654064965?lang=zh_cn&edition=full","pubTime":"2026-07-27 02:08","pubTimestamp":1785089293,"startTime":"0","endTime":"0","summary":"截至2026年7月24日收盘，君实生物报收于35.88元，下跌3.57%，换手率1.86%，成交量14.25万手，成交额5.18亿元。当日关注点交易信息汇总：7月24日君实生物主力资金净流入224.33万元，同时出现机构净买入1960.75万元的大宗交易。大宗交易7月24日君实生物现1笔大宗交易，机构净买入1960.75万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072700001017.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1583","01877","BK1161","BK1515"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://junshipharma.com","stockEarnings":[{"period":"1week","weight":0.0833},{"period":"1month","weight":0.0207},{"period":"3month","weight":-0.2054},{"period":"6month","weight":-0.0604},{"period":"1year","weight":-0.3467},{"period":"ytd","weight":-0.0736}],"compareEarnings":[{"period":"1week","weight":-0.0077},{"period":"1month","weight":0.0611},{"period":"3month","weight":-0.0279},{"period":"6month","weight":-0.051},{"period":"1year","weight":0.03},{"period":"ytd","weight":0.0009}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"上海君实生物医药科技股份有限公司是一家主要从事创新驱动生物制药业务的中国公司。该公司主营业务为创新药物的发现、临床研究和开发。该公司的主要产品包括特立普珠单抗注射液、依替维单抗、阿达木单抗注射液等用于治疗恶性肿瘤、自身免疫系统疾病、慢性代谢疾病、神经系统疾病和感染性疾病的药物。该公司还从事重组人源化抗PCSK9单克隆抗体注射液等药物的临床研发。该公司主要为国内外市场提供产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.098181},{"month":2,"riseRate":0.75,"avgChangeRate":0.062525},{"month":3,"riseRate":0.75,"avgChangeRate":0.059343},{"month":4,"riseRate":0.875,"avgChangeRate":0.105939},{"month":5,"riseRate":0.375,"avgChangeRate":-0.021039},{"month":6,"riseRate":0.375,"avgChangeRate":-0.04216},{"month":7,"riseRate":0.625,"avgChangeRate":-0.000677},{"month":8,"riseRate":0.25,"avgChangeRate":-0.025176},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.026161},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.004518},{"month":11,"riseRate":0.571429,"avgChangeRate":0.043753},{"month":12,"riseRate":0.571429,"avgChangeRate":0.085319}],"exchange":"SEHK","name":"君实生物","nameEN":"JUNSHI BIO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"君实生物(01877)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供君实生物(01877)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"君实生物,01877,君实生物股票,君实生物股票老虎,君实生物股票老虎国际,君实生物行情,君实生物股票行情,君实生物股价,君实生物股市,君实生物股票价格,君实生物股票交易,君实生物股票购买,君实生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"君实生物(01877)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供君实生物(01877)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}